Modern digital technologies can build in traceability from development to commercialization to optimize outcomes. As cell and gene therapy makes inroads in the life sciences marketplace, an important existing concept from this space has begun to draw more attention than it had previously: traceability.
Emerson’s Director of Life Sciences Strategy Michalle Adkins and Bob Lenich, business director of Emerson’s industrial software business share their thoughts in this article in Pharma Manufacturing magazine on traceability to ensure product efficacy.
Latest News
Emerson’s New Fixed Point Gas Detector Provides Fast and Reliable Detection without False Alarms
Rosemount 625IR Fixed Gas Detector is simple to set up, install, and maintain, with factory calibration that persists throughout its lifecycle
Emerson Streamlines Embedded Software Test for Hardware-in-the-Loop Engineers
NI test suite enables high fidelity software validation at faster speeds to improve time-to-market while reducing costs
Emerson and Zitara Partner to Enhance Battery Management Solutions
Collaboration builds on company’s investment in Zitara’s cutting-edge software through Emerson Ventures
